Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Microglial Activation”

39 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 39 results

Early research (Phase 1)Looking for participantsNCT03705715
What this trial is testing

Identifying Correlates of Brain Microglial Activation in Neuropsychiatric Syndromes: a Dimensional Approach

Who this might be right for
Neuropsychiatric Syndromes
The University of Texas Health Science Center, Houston 200
Testing effectiveness (Phase 2)UnknownNCT03230526
What this trial is testing

Identification of a Biomarker Predictive of Evolution of Parkinson Disease

Who this might be right for
Parkinson Disease
Nantes University Hospital 31
Not applicableStudy completedNCT02139696
What this trial is testing

Sphingosine-1 Phosphate -Receptor Targeting and Microglial Activation

Who this might be right for
Multiple Sclerosis
Turku University Hospital 10
Not applicableUnknownNCT05317871
What this trial is testing

Clearance Mechanisms in Atypical Neurodegenerative Diseases

Who this might be right for
Neurodegenerative DiseasesFrontotemporal Degeneration
Ludwig-Maximilians - University of Munich 80
Large-scale testing (Phase 3)UnknownNCT03691077
What this trial is testing

Effect of Ocrelizumab on Brain Innate Immune Microglial Cells Activation in MS Using PET-MRI With 18F-DPA714

Who this might be right for
Multiple SclerosisRelapsePrimary Progressive Multiple Sclerosis
Assistance Publique - Hôpitaux de Paris 51
Testing effectiveness (Phase 2)Ended earlyNCT01428505
What this trial is testing

[18F]PBR111 and Microglial Activation in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
GlaxoSmithKline 50
Not applicableUnknownNCT02319382
What this trial is testing

Measure of Microglial Activation in the Brain of Parkinson Disease Patients With PET

Who this might be right for
Parkinson's Disease With LRRK2 MutationHealthy ControlsParkinson's Disease Without LRRK2 Mutation
Assistance Publique - Hôpitaux de Paris 46
Not applicableActive Not RecruitingNCT05911178
What this trial is testing

Impact of Microglial Activation on Synaptic Density in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Centre Hospitalier St Anne 90
Not applicableLooking for participantsNCT07147309
What this trial is testing

Multimodal PET Imaging With 18F-FDG/SV2A/TSPO for Resection Planning in Drug-Resistant Epilepsy

Who this might be right for
EpilepsyPET / MRSynaptic Vesicle Proteins+2 more
Weibing Miao, PhD 60
Not applicableEnrolling By InvitationNCT04625049
What this trial is testing

Does Microglial Activation Promote Lesion Growth and Progression Among Multiple Sclerosis Patients

Who this might be right for
Multiple Sclerosis
Turku University Hospital 100
Not applicableLooking for participantsNCT06299592
What this trial is testing

Comparison of Microglial Activation in Severe Asthma and Healthy Controls

Who this might be right for
Asthma
University of Wisconsin, Madison 100
Not applicableUnknownNCT04171882
What this trial is testing

Microglial Cells Activation Imaging Using PET-CT With 18F-DPA714

Who this might be right for
Microglial Cells Activation Imaging
Weibing Miao, PhD 500
Large-scale testing (Phase 3)Study completedNCT03947827
What this trial is testing

Minocycline as Adjunctive Treatment for Treatment Resistant Depression

Who this might be right for
Treatment Resistant Depression
Centre for Addiction and Mental Health 76
Testing effectiveness (Phase 2)WithdrawnNCT03983252
What this trial is testing

Effect of Alemtuzumab on Microglial Activation Positron Emission Tomography (PET) in Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
Brigham and Women's Hospital
Early research (Phase 1)Study completedNCT01738347
What this trial is testing

Assess Safety, Bio-distribution, Radiation Dosimetry and Optimize the Imaging Protocol of GEH120714 (18F) Injection in Healthy Volunteers and Participants With Relapsing and Remitting Multiple Sclerosis (rrMS).

Who this might be right for
Relapsing-remitting Multiple Sclerosis (rrMS)
GE Healthcare 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04840979
What this trial is testing

Discovery and Validation of Genetic Variants Affecting Microglial Activation in Alzheimer's Disease

Who this might be right for
Alzheimer Disease
Columbia University 107
Early research (Phase 1)Temporarily pausedNCT03117530
What this trial is testing

Measuring Brain Inflammation in Autism

Who this might be right for
Autism Spectrum Disorder
University of California, Los Angeles 30
Very early researchWithdrawnNCT02405403
What this trial is testing

Microglial Activation Role In ALS (MARIA)

Who this might be right for
Amyotrophic Lateral Sclerosis
University Hospital, Tours
Not applicableActive Not RecruitingNCT03368677
What this trial is testing

Effect of Teriflunomide Treatment on Microglial Activation in an MS Patient Cohort at Risk of Progression

Who this might be right for
Multiple Sclerosis
Turku University Hospital 26
Early research (Phase 1)Study completedNCT03876002
What this trial is testing

Evaluation of Microglial Activation in ALS With [18F]PBR06 (Peripheral Benzodiazepine Receptor-06) PET

Who this might be right for
Healthy VolunteersAmyotrophic Lateral Sclerosis
Molecular NeuroImaging 23
Next Page